Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001671098 | SCV001885064 | benign | not provided | 2019-07-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24036952) |
Genome Diagnostics Laboratory, |
RCV002276854 | SCV002566262 | benign | Ehlers-Danlos syndrome | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002329703 | SCV002637486 | benign | Cardiovascular phenotype | 2019-01-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002495997 | SCV002799100 | likely benign | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001729963 | SCV001977746 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001729963 | SCV001978337 | benign | not specified | no assertion criteria provided | clinical testing |